GENE ONLINE|News &
Opinion
Blog

Clinical Trial
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
Anti-cancer
Samsung Biologics Inks CDO Contract with PharmAbcine to Develop Novel Drug
2020-04-08
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
COVID-19 Japan
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Trials & Approvals
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
COVID-19 Orphan Drug Designation
Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
2020-03-25
COVID-19 PARP Inhibitor
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
Trials & Approvals Chronic Fibrosis
Boehringer Ingelheim’s Ofev Becomes First FDA Approved Treatment for Progressive Interstitial Lung Diseases
2020-03-11
Trials & Approvals Cystinosis
Investigational Gene Therapy for Cystinosis Obtains FDA’s Orphan Drug Designation
2020-03-10
COVID-19 Influenza
First Potential Treatment for COVID-19 Greenlighted by Korean Authorities
2020-03-08
Trials & Approvals Anti-HIV
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
Asia-Pacific Atopic Dermatitis
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Technology Multiplex Genome Engineering
Using the Power of Multiplex Genome Engineering to Treat Cancer
2020-02-12
Deals
Venturing for Gold Mining from Real-World Data: GV Invests in Verana Health
2020-02-07
1 … 10 11 12 13 14
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top